191 related articles for article (PubMed ID: 12580928)
1. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
McCabe CJ; Khaira JS; Boelaert K; Heaney AP; Tannahill LA; Hussain S; Mitchell R; Olliff J; Sheppard MC; Franklyn JA; Gittoes NJ
Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
[TBL] [Abstract][Full Text] [Related]
4. A potential role for PTTG/securin in the developing human fetal brain.
Boelaert K; Tannahill LA; Bulmer JN; Kachilele S; Chan SY; Kim D; Gittoes NJ; Franklyn JA; Kilby MD; McCabe CJ
FASEB J; 2003 Sep; 17(12):1631-9. PubMed ID: 12958169
[TBL] [Abstract][Full Text] [Related]
5. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.
Hunter JA; Skelly RH; Aylwin SJ; Geddes JF; Evanson J; Besser GM; Monson JP; Burrin JM
Eur J Endocrinol; 2003 Feb; 148(2):203-11. PubMed ID: 12590639
[TBL] [Abstract][Full Text] [Related]
6. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
9. Genetic targets for the treatment of pituitary adenomas: focus on the pituitary tumor transforming gene.
McCabe C
Curr Opin Pharmacol; 2001 Dec; 1(6):620-5. PubMed ID: 11757818
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
[TBL] [Abstract][Full Text] [Related]
11. A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product.
Chien W; Pei L
J Biol Chem; 2000 Jun; 275(25):19422-7. PubMed ID: 10781616
[TBL] [Abstract][Full Text] [Related]
12. PTTG--a new pituitary tumour transforming gene.
McCabe CJ; Gittoes NJ
J Endocrinol; 1999 Aug; 162(2):163-6. PubMed ID: 10425453
[TBL] [Abstract][Full Text] [Related]
13. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma.
Mulla A; Christian HC; Solito E; Mendoza N; Morris JF; Buckingham JC
Clin Endocrinol (Oxf); 2004 Jan; 60(1):107-19. PubMed ID: 14678296
[TBL] [Abstract][Full Text] [Related]
14. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
[TBL] [Abstract][Full Text] [Related]
15. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
Shimon I; Hinton DR; Weiss MH; Melmed S
Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle dysregulation in pituitary oncogenesis.
Muşat M; Vax VV; Borboli N; Gueorguiev M; Bonner S; Korbonits M; Grossman AB
Front Horm Res; 2004; 32():34-62. PubMed ID: 15281339
[TBL] [Abstract][Full Text] [Related]
17. Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas.
Kanakis D; Kirches E; Mawrin C; Dietzmann K
Clin Endocrinol (Oxf); 2003 Feb; 58(2):151-5. PubMed ID: 12580929
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of PTTG and b-FGF in acute leukemia].
Cong J; Wang HY; Zhang CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):951-3. PubMed ID: 16403257
[TBL] [Abstract][Full Text] [Related]
19. In vivo expression and localization of the fibroblast growth factor system in the intact and lesioned rat peripheral nerve and spinal ganglia.
Grothe C; Meisinger C; Claus P
J Comp Neurol; 2001 Jun; 434(3):342-57. PubMed ID: 11331533
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumour transforming gene: a novel factor in pituitary tumour formation.
Heaney AP; Melmed S
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Oct; 13(3):367-80. PubMed ID: 10909429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
